Elsa Bernard
@Elsa2Bernard
Followers
837
Following
406
Media
4
Statuses
143
Computational Oncology 💻 | Cancer genomics 🧬 | Hematology 🩸 PI @GustaveRoussy | VS @TheCrick | Postdoc @CompOncMSK | PhD @institut_curie
France
Joined December 2019
@oriol_pich @cbailey_58 🙏 to the patients & families who participated in TRACERx and MSK IMPACT, our funders, our all collaborators who made this possible @AdamMead_Oxford @EvaGronroos @HSCwatcher @Bill_G_Grey @JulianDownward @IMalanchi @ZaccaSimo @Johanna_A_Joyce @CKBrierley and many others!
0
3
9
This all started from bioinformatics deep dive into genomics data and discussing crazy ideas with colleagues and friends @oriol_pich @cbailey_58 : 🩷🩷 to science 🩷🩷
1
0
8
Excited to see our @NEJM paper out on tumor-infiltrating CH, tumor evolution, and patient outcomes. A privilege to work w/ friends @oriol_pich and Maria Zagorulya with invaluable support from @PapaemmanuilLab and @CharlesSwanton
@MSKCancerCenter @TheCrick @GustaveRoussy 👇👇
🚨Thrilled to share our latest work: “Tumor-Infiltrating Clonal Hematopoiesis” @NEJM - we investigated how age-related blood mutations impact cancer when they infiltrate tumors, with @Elsa2Bernard Maria Zagorulya, @PapaemmanuilLab @CharlesSwanton + more https://t.co/PYUKWzSxV2
5
8
80
A pleasure (and fun!) to work w/ @MariaSirenko as she led this detective work 🕵️♀️on UBA1 mut in #MDSsm. Team work as always @MariaCreignou #IWG @MDSFoundation with the most supportive mentor @PapaemmanuilLab. Cant wait to see Maria's future work w/ @iannisaifantis1 🚀 Thread 👇👇
Which #MDSsm patients are most likely to have UBA1 mutations associated with #VEXAS syndrome? Our study now out in @BloodJournal: Molecular and clinical presentation of UBA1-mutated MDS by @PapaemmanuilLab, @Elsa2Bernard, @MariaCreignou, David Beck, MDS IWG-PM & @MDSFoundation
1
2
35
Helping put together⭐️Embracing #cancer complexity: Hallmarks of systemic disease⭐️in @CellCellPress was a unique experience! Honored to participate in mapping out the complexities of cancer as a systemic disease🎯.🙏@CharlesSwanton and all coauthors really for this endeavour!
An anniversary review on the Hallmarks of #cancer as a systemic disease, now @CellCellPress. An effort led by @CharlesSwanton @Elsa2Bernard and written together with many wonderful colleagues. https://t.co/t4TlKfPsI3
1
8
40
Congratulations @ypradat 🥳! Looking forward to working with you over the coming years! @ypradat and I first met while training in @PapaemmanuilLab and our scientific adventure continues 🚀 @GustaveRoussy @PrismCenter
I am thrilled to announce that I will be supported by a postdoctoral fellowship from @FondationARC for the next 3y to investigate the molecular features of treatment-related myeloid leukemias. Work under the supervision of @Elsa2Bernard at @GustaveRoussy and part of @PrismCenter.
1
3
17
Amazing work @CKBrierley and team!
Heading home from #ASH23? 👩💼🌞🌮Stuck in a line at security or facing a long layover? ✈️In withdrawal from all the amazing science? 🧪🧬 Read our preprint from my PhD work @UniofOxford @MRC_WIMM presented in the MPN session yesterday! https://t.co/uH3dzJ5ueD 1/n
0
0
5
Very happy 🥳to join @GustaveRoussy to lead a Computational Clinical Oncology group! The team will employ cancer genomics 🧬and stats 🎯to improve precision diagnostics, stratification & early detection. Special heme🩸focus #tMN #CHIP. More soon for job offers!
Le Dr Elsa Bernard a rejoint @GustaveRoussy en septembre dernier, en tant que cheffe de groupe de l'équipe Oncologie clinique computationnelle au sein de l'@Inserm U981 et de l'IHU @PrismCenter. Bienvenue à l'institut @Elsa2Bernard ! 🤝
26
8
210
The IPSS-M is a prognosis calculator for MDS patients. It combines genomic profiling with hematologic and cytogenetic parameters. This tool is intended for health care professionals to support with clinical decision making. Find our IPSS here: https://t.co/AgF9nhqbcj
0
5
8
Our editorial in @JCOPO_ASCO describing the #CHIP MTB @GustaveRoussy and thoughts for the future. Multidisciplinary effort as always! Pleasure to work with @JB_Micol and Aline Renneville
Happy to share our Edito on Gustave Roussy CHIP Molecular Tumor Board « Clonal Hematopoiesis in Patients With Cancer: How Much Should We Care? »
0
9
18
Happy to share our Edito on Gustave Roussy CHIP Molecular Tumor Board « Clonal Hematopoiesis in Patients With Cancer: How Much Should We Care? »
ascopubs.org
1
12
31
Many congratulations to @cbailey_58 for a stellar Phd defense yesterday 🥳! Chris is a dedicated hematologist, top notch bioinformatician, ecDNA world expert, cancer genomic gourou, and I am luck to call him my friend 💫. Much more to come from Chris in the future 🚀!
Yesterday @cbailey_58 passed his PhD viva 🥳 A brilliant scientist and kindred spirit, his presence has left an indelible mark on us all. I am grateful to have witnessed your journey 🥷The world gains an exceptional MD/PhD - I've gained a lifelong friend. Congrats Chris💜
1
2
11
🧬 Clonal Interception | Un programme scientifique précurseur pour anticiper le risque de #leucémie induite par de précédents traitements anticancéreux. Décryptage avec le Dr Jean-Baptiste Micol, hématologue à @GustaveRoussy et porteur du projet 👇
1
9
22
Proud to share our manuscript on clonal evolution during metastatic spread in high-risk neuroblastoma (HR-NB). A collaboration between @PapaemmanuilLab and Nai-Kong Cheung Labs in @MSKCancerCenter. https://t.co/QN91E5rOsY See the thread below.
nature.com
Nature Genetics - Genomic and transcriptomic analysis of 470 mostly high-risk neuroblastomas collected from 283 patients delineates subtype-specific evolutionary patterns and progression-related...
8
30
135
High-risk neuroblastoma (HR-NB) is a pediatric cancer characterized by overt metastatic disease at diagnosis, on-treatment progression and dismal outcomes. Our study, led by @gundem_gunes published in @NatureGenet today https://t.co/cmUo8MRYd8
#CheungLab #MSKKids @MSKCancerCenter
4
20
117
You can now access the IPSS-M through web, android and apple app store! Web: https://t.co/qg6zMV9fFv iOS: https://t.co/8HIpS3v1sz Android:
play.google.com
The IPSS-M is the newest MDS prognosis calculator which considers gene mutations
1
32
104
Groundbreaking study on the promotion of lung cancer by air pollution in never smokers. Congrats @WillHilliam @LimEmilia @DrClareWeeden and all involved. Climate health is human health. Act now 🌍
Today our important study on air pollutants in the promotion of lung cancer has been published in @Nature led by @WillHilliam @LimEmilia @DrClareWeeden @SwantonLab ...Thread below🧵 https://t.co/q1ICykmVox
1
0
13
What an outstanding Phd defense! Congratulations Dr. Sirenko and mentor @PapaemmanuilLab. @MariaSirenko you were fabulous so so proud of you!
Congratulations to @MariaSirenko and her mentor @PapaemmanuilLab for a couple of amazing research projects and an impressive PHD thesis! Happy that we had the chance to work together on the single cell mapping project!
1
1
14
WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint https://t.co/u3Zkh7TJLP. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.
0
0
4
In recognition of #MDSWorldAwarenessDay, we ask that you retweet this post to bring awareness to Myelodysplastic Syndromes—a rare blood cancer. Honor someone specific, tag a loved one, or share just because. Each and every share makes a difference! https://t.co/iNa2moFGZF
0
27
35